BioNexus Gene Lab Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
BioNexus Gene Lab Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
  • BioNexus Gene Lab Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.35M, a 48.4% increase year-over-year.
  • BioNexus Gene Lab Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$942K, a 69.6% increase year-over-year.
  • BioNexus Gene Lab Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$2.63M, a 639% decline from 2022.
  • BioNexus Gene Lab Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$356K, a 147% decline from 2021.
  • BioNexus Gene Lab Corp annual Net Income (Loss) Attributable to Parent for 2021 was $752K, a 31.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$942K -$1.35M +$1.26M +48.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-15
Q2 2024 -$2.21M $199K +$458K Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-15
Q1 2024 -$2.66M -$104K -$34.7K -50.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-15
Q4 2023 -$2.63M $308K +$465K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$3.09M -$2.61M -$2.53M -3271% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-15
Q2 2023 -$563K -$259K -$121K -87% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-15
Q1 2023 -$442K -$69.1K -$86.1K -505% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-15
Q4 2022 -$356K -$157K -$246K -276% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$110K -$77.4K -$373K -126% Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-03-26
Q2 2022 $263K -$139K -$167K -591% Apr 1, 2022 Jun 30, 2022 10-Q/A 2024-03-26
Q1 2022 $430K $17.1K -$322K -95% Jan 1, 2022 Mar 31, 2022 10-Q/A 2024-03-26
Q4 2021 $752K $89.2K +$263K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $488K $295K +$60.9K +26% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $427K $28.3K +$64.1K Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 $363K $339K -$731K -68.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 $1.09M -$174K -$81.6K -88.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-06
Q3 2020 $1.18M $234K +$256K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $919K -$35.8K +$34.6K +49.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $885K $1.07M +$1.13M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$246K -$92.6K +$24.4K +20.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$271K -$22K +$66.9K +75.2% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-09
Q2 2019 -$338K -$70.4K -$30.9K -78.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$307K -$61.5K -$333K -123% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $26.5K -$117K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-31
Q3 2018 -$89K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$39.5K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $272K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.